\-\ Texto\\:\\ \ \(0\)\
\-\ multiple\\ sub\\-centimeter\\ enhancing\\ nodular\\ lesions\\ of\\ the\\ thoracic\\ spinal\\ cord\\ and\\ conus\\ medullaris\\.\\ \\ lesions\\ are\\ isointense\\ on\\ t2wi\\.\ \(0\)\
\-\ spinal\\ metastases\ \(1\)\
\-\ cerebral\\ glioblastoma\\,\\ ependymoma\\,\\ anaplastic\\ astrocytoma\\,\\ and\\ posterior\\ fossa\\ medulloblastoma\\ are\\ the\\ most\\ common\\ cns\\ primary\\ tumors\\ that\\ metastasize\\ to\\ the\\ spinal\\ subarachnoid\\ space\\.\\ \\ non\\-cns\\ tumors\\ that\\ commonly\\ seed\\ the\\ subarachnoid\\ space\\ include\\ carcinoma\\ of\\ the\\ lung\\ or\\ breast\\,\\ melanoma\\,\\ lymphoma\\,\\ and\\ leukemia\\.\ \(0\)\
\-\ 63\\ yo\\ asymptomatic\\ man\\ presents\\ for\\ annual\\ spine\\ screening\\.\\ \\ patient\\ reports\\ a\\ history\\ of\\ a\\ spinal\\ cord\\ tumor\\ removed\\ \\‚\\Ä\\ú4\\ or\\ 5\\ years\\ ago\\,\\‚\\Ä\\ù\\ though\\ he\\ doesn\\‚\\Ä\\ôt\\ recall\\ the\\ type\\ of\\ tumor\\ and\\ was\\ treated\\ only\\ with\\ surgery\\.\ \(0\)\
\-\ these\\ findings\\ are\\ most\\ likely\\ secondary\\ to\\ the\\ original\\,\\ unknown\\ tumor\\.\\ \\ given\\ the\\ focal\\ nature\\ of\\ the\\ original\\ tumor\\,\\ along\\ with\\ the\\ patient\\'s\\ prolonged\\ course\\ \\(a\\ 2002\\ spinal\\ mri\\ was\\ negative\\ for\\ mets\\)\\ and\\ radiographic\\ findings\\,\\ ependymoma\\ is\\ considered\\ most\\ likely\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ spinal\\:\\ 0\\.09216193404757789\ \(0\)\
\-\ original\\:\\ 0\\.06146923322002639\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.05002505216692086\ \(0\)\
\-\ tumor\\:\\ 0\\.048005597629176174\ \(0\)\
\-\ non\\-cns\\:\\ 0\\.04648738635721921\ \(0\)\
\-\ ependymoma\\:\\ 0\\.04608537153238267\ \(0\)\
\-\ seed\\:\\ 0\\.04341012356344818\ \(0\)\
\-\ doesn\\:\\ 0\\.04341012356344818\ \(0\)\
\-\ sub\\-centimeter\\:\\ 0\\.041383182378983044\ \(0\)\
\-\ cord\\:\\ 0\\.03912257735187231\ \(0\)\
\-\ tumors\\:\\ 0\\.038671281417716884\ \(0\)\
\-\ recall\\:\\ 0\\.038136215507099384\ \(0\)\
\-\ metastasize\\:\\ 0\\.03640319097425733\ \(0\)\
\-\ most\\:\\ 0\\.03565364713966403\ \(0\)\
\-\ medullaris\\:\\ 0\\.03476503606170527\ \(0\)\
\-\ space\\:\\ 0\\.03405490369971849\ \(0\)\
\-\ anaplastic\\:\\ 0\\.03241886276795995\ \(0\)\
\-\ conus\\:\\ 0\\.03103588420383646\ \(0\)\
\-\ t2wi\\:\\ 0\\.030883367288268446\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.029911872423231567\ \(0\)\
\-\ mets\\:\\ 0\\.029660832083469105\ \(0\)\
\-\ likely\\:\\ 0\\.02903963814380309\ \(0\)\
\-\ 63\\:\\ 0\\.02854205409675168\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.028341232287910766\ \(0\)\
\-\ 2002\\:\\ 0\\.028146889744427507\ \(0\)\
\-\ lesions\\:\\ 0\\.027560969955951177\ \(0\)\
\-\ prolonged\\:\\ 0\\.027342483764761706\ \(0\)\
\-\ leukemia\\:\\ 0\\.02641386521158545\ \(0\)\
\-\ cns\\:\\ 0\\.026342573298049288\ \(0\)\
\-\ melanoma\\:\\ 0\\.026272115227186688\ \(0\)\
\-\ annual\\:\\ 0\\.025800716450682184\ \(0\)\
\-\ isointense\\:\\ 0\\.02530360185015204\ \(0\)\
\-\ nature\\:\\ 0\\.024366468671691767\ \(0\)\
\-\ though\\:\\ 0\\.023876434699077596\ \(0\)\
\-\ t\\:\\ 0\\.023829554334968833\ \(0\)\
\-\ removed\\:\\ 0\\.023208878275340912\ \(0\)\
\-\ metastases\\:\\ 0\\.02199236415688545\ \(0\)\
\-\ screening\\:\\ 0\\.021958038728484015\ \(0\)\
\-\ findings\\:\\ 0\\.02191369802156578\ \(0\)\
\-\ nodular\\:\\ 0\\.02159283016332477\ \(0\)\
\-\ are\\:\\ 0\\.021051937455354247\ \(0\)\
\-\ fossa\\:\\ 0\\.020980720666874272\ \(0\)\
\-\ considered\\:\\ 0\\.020780375957497873\ \(0\)\
\-\ reports\\:\\ 0\\.020752291541197804\ \(0\)\
\-\ unknown\\:\\ 0\\.020089635545930764\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.019990061437790942\ \(0\)\
\-\ thoracic\\:\\ 0\\.019843719916290675\ \(0\)\
\-\ radiographic\\:\\ 0\\.019538339709570685\ \(0\)\
\-\ commonly\\:\\ 0\\.0194248882135882\ \(0\)\
\-\ course\\:\\ 0\\.0194248882135882\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.01922590914324795\ \(0\)\
\-\ ago\\:\\ 0\\.01916101699275451\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.019118140680893885\ \(0\)\
\-\ breast\\:\\ 0\\.018991312914641883\ \(0\)\
\-\ cerebral\\:\\ 0\\.017834015070867897\ \(0\)\
\-\ that\\:\\ 0\\.01778290034408221\ \(0\)\
\-\ given\\:\\ 0\\.01764707465371291\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.017401159024072816\ \(0\)\
\-\ type\\:\\ 0\\.017353158002089822\ \(0\)\
\-\ along\\:\\ 0\\.017012372752159735\ \(0\)\
\-\ spine\\:\\ 0\\.016952431000032218\ \(0\)\
\-\ \\,\\:\\ 0\\.016307835272125745\ \(0\)\
\-\ enhancing\\:\\ 0\\.016144298390872044\ \(0\)\
\-\ yo\\:\\ 0\\.015490069417486518\ \(0\)\
\-\ only\\:\\ 0\\.01547838348484901\ \(0\)\
\-\ treated\\:\\ 0\\.015408739976408792\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.01538570325087624\ \(0\)\
\-\ negative\\:\\ 0\\.015374217839607678\ \(0\)\
\-\ primary\\:\\ 0\\.015249302788528292\ \(0\)\
\-\ years\\:\\ 0\\.015115922512159534\ \(0\)\
\-\ 5\\:\\ 0\\.015061207364121467\ \(0\)\
\-\ lung\\:\\ 0\\.014910597109871965\ \(0\)\
\-\ lymphoma\\:\\ 0\\.014712039966201722\ \(0\)\
\-\ focal\\:\\ 0\\.014701768699628928\ \(0\)\
\-\ carcinoma\\:\\ 0\\.014589925722987148\ \(0\)\
\-\ include\\:\\ 0\\.014440683662833053\ \(0\)\
\-\ secondary\\:\\ 0\\.014391746786197637\ \(0\)\
\-\ he\\:\\ 0\\.014362574349596504\ \(0\)\
\-\ 4\\:\\ 0\\.014343204248066538\ \(0\)\
\-\ common\\:\\ 0\\.013471489228652996\ \(0\)\
\-\ these\\:\\ 0\\.013396654770830362\ \(0\)\
\-\ surgery\\:\\ 0\\.012499994363616115\ \(0\)\
\-\ man\\:\\ 0\\.012174288211385538\ \(0\)\
\-\ or\\:\\ 0\\.012066539144141054\ \(0\)\
\-\ was\\:\\ 0\\.011906958098960082\ \(0\)\
\-\ posterior\\:\\ 0\\.011865292462062945\ \(0\)\
\-\ mri\\:\\ 0\\.011826962981413374\ \(0\)\
\-\ \\'s\\:\\ 0\\.011349678423897861\ \(0\)\
\-\ multiple\\:\\ 0\\.01084220484023656\ \(0\)\
\-\ presents\\:\\ 0\\.010515929491011601\ \(0\)\
\-\ patient\\:\\ 0\\.010320384709836001\ \(0\)\
\-\ for\\:\\ 0\\.008784435525815846\ \(0\)\
\-\ the\\:\\ 0\\.008328270162869024\ \(0\)\
\-\ a\\:\\ 0\\.007167466297926529\ \(0\)\
\-\ history\\:\\ 0\\.007109726130765563\ \(0\)\
\-\ and\\:\\ 0\\.005421958003982484\ \(0\)\
\-\ to\\:\\ 0\\.005145398896903449\ \(0\)\
\-\ on\\:\\ 0\\.004360789231117036\ \(0\)\
\-\ \\(\\:\\ 0\\.004351576664119642\ \(0\)\
\-\ \\)\\:\\ 0\\.004298419832007862\ \(0\)\
\-\ of\\:\\ 0\\.0035091506264454345\ \(0\)\
\-\ is\\:\\ 0\\.0033872938456911183\ \(0\)\
\-\ \\.\\:\\ 0\\.0017108210167395795\ \(0\)\
\-\ with\\:\\ 0\\.0014096888685528886\ \(0\)\
